Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia

Clinical trial NCT03439124 · COMPLETED

Trial details

NCT number: NCT03439124
Sponsor: Basilea Pharmaceutica
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Community-acquired Pneumonia (CAP)Hospital-acquired Pneumonia (HAP)

Start date: 2017-11-27
Primary completion: 2020-03-16
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.